High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, Odd Terje Brustugun, Kjersti Hornslien, Tesfaye Madebo, Seppo W. Langer, Tine Schytte, Jan Nyman, Signe Risum, Georgios Tsakonas, Jens Engleson, Tarje Onsøien Halvorsen
Topics & Concepts
MedicineOpen labelStage (stratigraphy)Radiation therapyOncologyLung cancerRandomized controlled trialInternal medicineRadiologyBiologyPaleontologyLung Cancer Research StudiesLung Cancer Treatments and MutationsNeuroendocrine Tumor Research Advances